Hospital for Special Surgery
New York, NY, United States
Melissa Flores, MPH, LCSW is the Assistant Director of the Office of Health Equity at the Hospital for Special Surgery (HSS). Ms. Flores works alongside the Chief Health Equity Officer to lead the HSS Health Equity Strategic Plan with a goal of achieving equitable care for all patients. She has spearheaded initiatives to collect, analyze and intervene on health equity-related data, such as social determinants of health (SDOH), leading the implementation of SDOH collection across pediatric outpatient and adult inpatient settings. With over a decade of experience, she works cross-departmentally to identify and address variances in care specific to orthopedic and rheumatology. As a leader of the hospital-wide LGBTQIA+ Committee, she plays a key role in achieving the hospital’s LGBTQ+ Healthcare Equality Leader designation. Prior to this role, Ms. Flores was Social Work Coordinator of the Charla de Lupus (Lupus Chat)® Program, a national bilingual program offering people with lupus and their families peer health support and education. Holding dual Master’s degrees in Social Work and Public Health from Columbia University, Ms. Flores is driven by a deep commitment to centering humanity in healthcare and building trust across communities.
Sunday, October 26, 2025
2:45 PM - 3:45 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Diving into Data: A Hospital’s SDOH Integration Journey
Sunday, October 26, 2025
4:30 PM - 5:00 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Monday, October 27, 2025
10:00 AM - 11:30 AM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Working Toward Solutions to Address Health Inequalities in Pediatric Rheumatology
Tuesday, October 28, 2025
8:30 AM - 8:45 AM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Tuesday, October 28, 2025
8:45 AM - 9:00 AM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose